Trial
NCT05501574
An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
TFF Pharmaceuticals, Inc.
Collaborators
Novotech (Australia) Pty Limited
Condition
Lung Transplant Rejection
Intervention
Tacrolimus Inhalation Powder
Why stopped
Study was terminated due to funding constraints
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-06